Vol 48 No 8

Jonathan Rubenstein, MD, and Mark Painter tackle a question regarding billing for a stone procedure.

"Therapeutic strategies are needed in the management of NMIBC that recurs after gold-standard intravesical BCG," Gomella writes.

Against the backdrop of a new guideline for advanced prostate cancer, Robert A. Dowling, MD, describes how you might measure adherence to guidelines in your own practice.

Increased usage of bladder diagrams was observed following implementation of the program.

E/M guidelines direct code selection based on face-to-face time with patient.

Investigators found that while patients without pain had an overall survival of 56 months, patients with pain had an overall survival of only 27 months.

Converting funds to Roth dollars is among the most effective strategies.

Stone embedded in bladder wall, causing slow bleed

A multidisciplinary panel outlines criteria for stratifying risk for genitourinary malignancy in patients with microhematuria.

Feasibility study results indicate the nonimplanted, intravaginal device is safe and comfortable.

“It’s case dependent. For appropriately selected patients, partial nephrectomy is preferred," says one urologist.

The phase 3 CONDOR study demonstrated excellent diagnostic performance with 18F-DCFPyL–PET/CT in men with biochemically relapsed prostate cancer, even at very low PSA values.

A study found no association between Black race and risk of skeletal-related events and all-cause mortality in men with newly diagnosed, bone metastatic castration-resistant prostate cancer.

Findings create opportunity to develop precision medicine options for this underserved patient population.

Steven A. Kaplan, MD, explains the updates in the AUA 2020 guideline on lower urinary tract symptoms secondary to benign prostatic hyperplasia.

The Soltive Laser System, which uses thulium fiber laser technology, has been shown to generate finer particulate and dusted stones in half the time as a standard holmium yttrium aluminium garnet laser.

Alan W. Shindel, MD, provides an expert summary and analysis of the 2020 AUA Guidelines for Disorders of Ejaculation.

William Lowrance, MD, and Michael S. Cookson, MD, highlight the core components of the new AUA Guideline for Advanced Prostate Cancer.

The American Urological Association, American Society for Radiation Oncology, and Society of Urologic Oncology have released a joint guideline for advanced prostate cancer to address the growing treatment options and complexity of the paradigm.

The guidelines are an evidence-based clinical reference for the treatment of patients with lower urinary tract symptoms secondary to BPH.